Literature DB >> 20167792

Radiation exposure of patients and personnel from a PET/CT procedure with 18F-FDG.

S Leide-Svegborn1.   

Abstract

The positron emission tomography (PET)/computed tomography (CT) camera is a combination of a PET camera and a CT. The image from the PET camera is based on the detection of radiation that is emitted from a radioactive tracer, which has been given to the patient as an intravenous injection. The radiation that is emitted from the radioactive tracer is more energetic than any other radiation used in medical diagnostic procedures and this requires special radiation protection routines. The CT image is based on the detection of radiation produced from an X-ray tube and transmitted through the patient. The radiation exposure of the personnel during the CT procedure is generally very low. Regarding radiation exposure of the patient, it is important to notice whether a CT scan has been performed prior to the PET/CT in order to avoid any unnecessary irradiation. The total effective dose to the patient from a PET/CT procedure is approximately 10 mSv. The major part comes from internal irradiation due to radiopharmaceuticals within the patients (e.g. (18)F-FDG: approximately 6-7 mSv), and a minor part is due to the CT scan (low-dose CT scan: approximately 2-4 mSv). If a full diagnostic CT investigation is performed, the effective dose may be considerably higher. If the patient is pregnant, a PET/CT procedure should be avoided or postponed, unless it is vital for the patient. An interruption in breastfeeding is not necessary after a PET/CT procedure of the nursing mother. Close contact between the patient and a small child should however be avoided for a couple of hours after the administration of the radiopharmaceutical. The radiation dose to the personnel arises mainly due to handling of the radiopharmaceuticals (syringe withdrawal, injection, waste handling, etc.) and from close contact to the patient. This radiation dose can be limited by using the inverse-square law, i.e. by using the fact that the absorbed dose decreases substantially with increasing distance between the radiation source and the personnel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20167792     DOI: 10.1093/rpd/ncq026

Source DB:  PubMed          Journal:  Radiat Prot Dosimetry        ISSN: 0144-8420            Impact factor:   0.972


  23 in total

1.  PET/CT in lung cancer: Influence of contrast medium on quantitative and clinical assessment.

Authors:  Florian F Behrendt; Yavuz Temur; Frederik A Verburg; Moritz Palmowski; Thomas Krohn; Hubertus Pietsch; Christiane K Kuhl; Felix M Mottaghy
Journal:  Eur Radiol       Date:  2012-06-04       Impact factor: 5.315

Review 2.  Positron emission tomography imaging approaches for external beam radiation therapies: current status and future developments.

Authors:  P M Price; M M Green
Journal:  Br J Radiol       Date:  2011-03-22       Impact factor: 3.039

3.  Recommendations of the Spanish Societies of Radiation Oncology (SEOR), Nuclear Medicine & Molecular Imaging (SEMNiM), and Medical Physics (SEFM) on (18)F-FDG PET-CT for radiotherapy treatment planning.

Authors:  Begoña Caballero Perea; Antonio Cabrera Villegas; José Miguel Delgado Rodríguez; María José García Velloso; Ana María García Vicente; Carlos Huerga Cabrerizo; Rosa Morera López; Luis Alberto Pérez Romasanta; Moisés Sáez Beltrán
Journal:  Rep Pract Oncol Radiother       Date:  2012-11-17

4.  Quantifying skeletal burden in fibrous dysplasia using sodium fluoride PET/CT.

Authors:  Wouter van der Bruggen; Marlous Hagelstein-Rotman; Lioe-Fee de Geus-Oei; Frits Smit; P D Sander Dijkstra; Natasha M Appelman-Dijkstra; Dennis Vriens
Journal:  Eur J Nucl Med Mol Imaging       Date:  2019-12-24       Impact factor: 9.236

5.  ¹⁸F-FDG PET/CT and 3.0-T whole-body MRI for the detection of distant metastases and second primary tumours in patients with untreated oropharyngeal/hypopharyngeal carcinoma: a comparative study.

Authors:  Sheng-Chieh Chan; Hung-Ming Wang; Tzu-Chen Yen; Chien-Yu Lin; Shy-Chyi Chin; Chun-Ta Liao; Yau-Yau Wai; Jiun-Jie Wang; Shu-Hang Ng
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-05-13       Impact factor: 9.236

6.  [Principles of PET].

Authors:  B Beuthien-Baumann
Journal:  Radiologe       Date:  2018-05       Impact factor: 0.635

7.  Pilot pharmacokinetic and dosimetric studies of (18)F-FPPRGD2: a PET radiopharmaceutical agent for imaging α(v)β(3) integrin levels.

Authors:  Erik S Mittra; Michael L Goris; Andrei H Iagaru; Arash Kardan; Lindee Burton; Rhona Berganos; Edwin Chang; Shuanglong Liu; Bin Shen; Frederick T Chin; Xiaoyuan Chen; Sanjiv S Gambhir
Journal:  Radiology       Date:  2011-04-18       Impact factor: 11.105

8.  The value of F-18 fluorodeoxyglucose positron emission tomography/computed tomography in asymptomatic examinees with unexplained elevated blood carcinoembryonic antigen levels.

Authors:  Wenfeng Li; Weiwei Yin; Rongying Ou; Ting Chen; Lingling Xiong; Dezhi Cheng; Deyao Xie; Xiangwu Zheng; Yunsheng Xu; Liang Zhao
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-10-24       Impact factor: 9.236

9.  Excretion of radionuclides in human breast milk after nuclear medicine examinations. Biokinetic and dosimetric data and recommendations on breastfeeding interruption.

Authors:  Sigrid Leide-Svegborn; Lars Ahlgren; Lennart Johansson; Sören Mattsson
Journal:  Eur J Nucl Med Mol Imaging       Date:  2016-01-06       Impact factor: 9.236

Review 10.  Future imaging of atherosclerosis: molecular imaging of coronary atherosclerosis with (18)F positron emission tomography.

Authors:  Daniel J Scherer; Peter J Psaltis
Journal:  Cardiovasc Diagn Ther       Date:  2016-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.